Patent · US Active

PSMA imaging agents

US12122851B2 · kind B2 · utility

0Cited by

2References

11Claims

0Family size

Assignee

Siemens Medical Solutions USA, Inc. · US

Inventors

Eric Wang · Yonkers, US
Hartmuth C. Kolb · El Segundo, US
Anna Katrin Szardenings · San Diego, US
Changhui Liu · Los Angeles, US
Joseph C. Walsh · Santa Monica, US
Gang Chen · Sammamish, US
Anjana Sinha · San Diego, US
Dhanalakshmi Kasi · Los Angeles, US
Chul Yu · Los Angeles, US
Umesh B. Gangadharmath · Los Angeles, US
Wei Zhang · San Diego, US
Tieming Zhao · Los Angeles, US
Vani P. Mocharla · Los Angeles, US

Key dates

Filing date	Aug 21, 2020
Grant date	Oct 22, 2024
Priority date	—
Expiry date	Sep 22, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.